These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12928135)

  • 1. [Movement disorders and botulinum toxin in neurology].
    Sangla S; Trocello JM; Bourdain F; Vidal JS; Gallouedec G; Vidailhet M
    Ann Readapt Med Phys; 2003 Jul; 46(6):307-11. PubMed ID: 12928135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of movement disorders using botulinum toxin].
    Burgunder JM
    Schweiz Med Wochenschr; 1992 Sep; 122(36):1311-6. PubMed ID: 1411387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin in motor disorders: practical considerations with emphasis on interventional neurophysiology.
    Traba López A; Esteban A
    Neurophysiol Clin; 2001 Aug; 31(4):220-9. PubMed ID: 11596529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of botulinum toxin type B in movement disorders and autonomic symptoms.
    Wan XH; Vuong KD; Jankovic J
    Chin Med Sci J; 2005 Mar; 20(1):44-7. PubMed ID: 15844312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on the neurologic applications of botulinum toxins.
    Evidente VG; Adler CH
    Curr Neurol Neurosci Rep; 2010 Sep; 10(5):338-44. PubMed ID: 20567945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current clinical applications of botulinum toxin.
    Truong DD; Stenner A; Reichel G
    Curr Pharm Des; 2009; 15(31):3671-80. PubMed ID: 19925419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Botulinum toxin in neurology].
    Vidailhet M
    Rev Med Interne; 2005 Jul; 26(7):531-3. PubMed ID: 15975692
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of various movement disorders with botulinum A toxin injection: an experience of 900 patients.
    Poungvarin N; Devahastin V; Viriyavejakul A
    J Med Assoc Thai; 1995 Jun; 78(6):281-8. PubMed ID: 7561552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Movement, visceral and autonomic disorders: use of botulinum toxin.
    Moore AP
    Hosp Med; 2003 Aug; 64(8):452-9. PubMed ID: 12958755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Simpson DM; Blitzer A; Brashear A; Comella C; Dubinsky R; Hallett M; Jankovic J; Karp B; Ludlow CL; Miyasaki JM; Naumann M; So Y;
    Neurology; 2008 May; 70(19):1699-706. PubMed ID: 18458230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum toxin and spinal cord injury].
    Ben Smaïl D; Denys P; Bussel B
    Ann Readapt Med Phys; 2003 Jul; 46(6):296-8. PubMed ID: 12928132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
    Tan AK
    Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical].
    Schnider P; Voller B; Moraru K; Auff E
    Wien Klin Wochenschr; 1999 Oct; 111(20):825-9. PubMed ID: 10586486
    [No Abstract]   [Full Text] [Related]  

  • 16. Botulinum toxin for the treatment of movement disorders.
    Thenganatt MA; Fahn S
    Curr Neurol Neurosci Rep; 2012 Aug; 12(4):399-409. PubMed ID: 22661378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Digestive tract and botulinum toxin].
    Gaudric M; Chaussade S
    Ann Readapt Med Phys; 2003 Jul; 46(6):353-60. PubMed ID: 12928143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A re-evaluation of the mechanism of action of botulinum toxin on facial movement disorders in man.
    Leon-S FE; Arimura K; Chavez AM
    Med Hypotheses; 1998 Oct; 51(4):305-7. PubMed ID: 9824836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting improvement in motor disability in writer's cramp treated with botulinum toxin.
    Djebbari R; du Montcel ST; Sangla S; Vidal JS; Gallouedec G; Vidailhet M
    J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1688-91. PubMed ID: 15548483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Botulinum toxin in headache].
    Simon O; Raibaut P; Faucher M; Sheik-Ismael S; Amarenco G
    Ann Readapt Med Phys; 2003 Jul; 46(6):312-8. PubMed ID: 12928136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.